Task: Answer the multiple-choice question.
Query: Which drug exhibits a -1.044\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
a: COc1ccc(CN2C(=NC(=O)C3CCCO3)SC3CS(=O)(=O)CC32)cc1
b: CCCNc1oc(-c2cccc3ccccc23)nc1C#N
Answer: a. COc1ccc(CN2C(=NC(=O)C3CCCO3)SC3CS(=O)(=O)CC32)cc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
COc1ccc(CN2C(=NC(=O)C3CCCO3)SC3CS(=O)(=O)CC32)cc1
COc1ccc(CN2C(=NC(=O)C3CCCO3)SC3CS(=O)(=O)CC32)cc1
N-[3-[(4-methoxyphenyl)methyl]-5,5-dioxo-3a,4,6,6a-tetrahydrothieno[3,4-d][1,3]thiazol-2-ylidene]oxolane-2-carboxamide